Increased Circulating Visfatin Is Associated With Progression of Kidney Disease in Non-Diabetic Hypertensive Patients

Plasma visfatin/nicotinamide phosphoribosyltransferase levels in hypertensive elderly – results from the PolSenior substudy

(2015) Piotr Kocelak et al.   Journal of the American Society of Hypertension

Visfatin/Nampt induces telomere damage and senescence in human endothelial cells

(2014) Laura A. Villalobos et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Reduction of Circulating Endothelial Progenitor Cell Level Is Associated with Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary and Peripheral Interventions

(2014) Chia-Hung Chiang et al.   PLoS One

Body Mass Index and Early Kidney Function Decline in Young Adults: A Longitudinal Analysis of the CARDIA (Coronary Artery Risk Development in Young Adults) Study

(2013) Vanessa Grubbs et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Did Akhenaten Have the Antley–Bixler Syndrome?

(2013) Irwin M. Braverman   ANNALS OF INTERNAL MEDICINE

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Assessment of the CKD-EPI Equation to Estimate Glomerular Filtration Rate in Adults from a Chinese CKD Population

(2013) Y Liao et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Progression of Kidney Disease in Non-Diabetic Patients with Coronary Artery Disease: Predictive Role of Circulating Matrix Metalloproteinase-2, -3, and -9

(2013) Ta-Wei Hsu et al.   PLoS One

Increased Circulating Endothelial Apoptotic Microparticle to Endothelial Progenitor Cell Ratio Is Associated with Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients

(2013) Chien-Yi Hsu et al.   PLoS One

Visfatin as a Novel Mediator Released by Inflamed Human Endothelial Cells

(2013) Tania Romacho et al.   PLoS One

Visfatin Stimulates a Cellular Renin-Angiotensin System in Cultured Rat Mesangial Cells

(2011) Qiong Huang et al.   ENDOCRINE RESEARCH

Visfatin-induced lipid raft redox signaling platforms and dysfunction in glomerular endothelial cells

(2010) Krishna M. Boini et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Visfatin/PBEF and Atherosclerosis-Related Diseases

(2010) Theodosios Filippatos et al.   Current Vascular Pharmacology

Different actions of losartan and ramipril on adipose tissue activity and vascular remodeling biomarkers in hypertensive patients

(2010) Giuseppe Derosa et al.   HYPERTENSION RESEARCH

Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients

(2010) Giuseppe Derosa et al.   HYPERTENSION RESEARCH

Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria

(2010) Po-Hsun Huang et al.   JOURNAL OF HYPERTENSION

Normalization of endothelial dysfunction following renal transplantation is accompanied by a reduction of circulating visfatin/NAMPT. A novel marker of endothelial damage?

(2009) Mahmut Ilker Yilmaz et al.   CLINICAL TRANSPLANTATION

Effect of renin-angiotensin-aldosterone system (RAAS) blockade on visfatin levels in diabetic nephropathy

(2009) TAYFUN EYILETEN et al.   NEPHROLOGY

Visfatin, a New Adipocytokine, Is Predominantly Related to Inflammation/Endothelial Damage in Kidney Allograft Recipients

(2009) J. Malyszko et al.   TRANSPLANTATION PROCEEDINGS

Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure

(2008) J Malyszko et al.   Advances in Medical Sciences

Nuclear Factor- B Induction by Visfatin in Human Vascular Endothelial Cells: Its role in MMP-2/9 production and activation

(2008) R. Adya et al.   DIABETES CARE